TYDEMY
Live / Registered — Registered — Section 8 accepted (as of 09 Apr 2025)
What this means for you
Registered since 18 Sept 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Sept 2028: the §8 & §9 renewal).
Record
- Serial number
- 87101464
- Registration number
- 5566311
- Mark type
- Word mark
- Filed
- 12 Jul 2016
- Published for opposition
- 08 Nov 2016
- Registered
- 18 Sept 2018
- Next maintenance filing
- §8 & §9 renewal, due by 18 Sept 2028 (grace period to 18 Mar 2029)
- Attorney of record
- Robert L. Powley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Owner
- Lupin Limited, Mumbai, IN
- Lupin Limited, Mumbai, IN
- Lupin Limited, Mumbai, IN
Prosecution history
- 09 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 09 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 07 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Sept 2024 — TEAS SECTION 8 RECEIVED
- 18 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jul 2018 — USE AMENDMENT FILED
- 25 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 08 Dec 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2017 — SOU EXTENSION 2 GRANTED
- 06 Dec 2017 — SOU EXTENSION 2 FILED